All Stories

  1. Enterovirus D68 infection in cotton rats results in systemic inflammation with detectable viremia associated with extracellular vesicle and neurologic disease
  2. An adenoviral vector encoding an inflammation-inducible antagonist, HMGB1 Box A, as a novel therapeutic approach to inflammatory diseases
  3. Preclinical development of the TLR4 antagonist FP12 as a drug lead targeting the HMGB1/MD-2/TLR4 axis in lethal influenza infection
  4. Optimising Bioprinting Nozzles through Computational Modelling and Design of Experiments
  5. Development of Respiratory Syncytial Virus Vaccine Candidates for the Elderly
  6. Human Metapneumovirus (hMPV) Infection and MPV467 Treatment in Immunocompromised Cotton Rats Sigmodon hispidus
  7. SARS-CoV-2 infection augments species- and age-specific predispositions in cotton rats
  8. Correlative outcomes of maternal immunization against RSV in cotton rats
  9. Evidence for Interplay Between the Renin–Angiotensin System and Toll-Like Receptor 4 Signaling Pathways in the Induction of Virus-Induced Acute Lung Injury
  10. Species-specific transcriptomic changes upon respiratory syncytial virus infection in cotton rats
  11. Protection against influenza-induced Acute Lung Injury (ALI) by enhanced induction of M2a macrophages: possible role of PPARγ/RXR ligands in IL-4-induced M2a macrophage differentiation
  12. Evolution of protection after maternal immunization for respiratory syncytial virus in cotton rats
  13. Targeting TLR4 Signaling to Blunt Viral-Mediated Acute Lung Injury
  14. Microbial community structure and composition is associated with host species and sex in Sigmodon cotton rats
  15. HUMAN ADENOVIRUS TYPE 4 COMPRISES TWO MAJOR PHYLOGROUPS WITH DISTINCT REPLICATIVE FITNESS AND VIRULENCE PHENOTYPES
  16. A mouse model of human TLR4 D299G/T399I SNPs reveals mechanisms of altered LPS and pathogen responses
  17. Effect of aging on immunogenicity and efficacy of inactivated influenza vaccines in cotton rats Sigmodon hispidus
  18. Early or Late Bacterial Lung Infection Increases Mortality After Traumatic Brain Injury in Male Mice and Chronically Impairs Monocyte Innate Immune Function
  19. Comparisons of Antibody Populations in Different Pre-Fusion F VLP-Immunized Cotton Rat Dams and Their Offspring
  20. Select targeting of intracellular Toll-interleukin-1 receptor resistance domains for protection against influenza-induced disease
  21. Classical Drug Digitoxin Inhibits Influenza Cytokine Storm, With Implications for Covid-19 Therapy
  22. Herpes Simplex Virus 1 Induces Brain Inflammation and Multifocal Demyelination in the Cotton Rat Sigmodon hispidus
  23. Alternative Virus-Like Particle-Associated Prefusion F Proteins as Maternal Vaccines for Respiratory Syncytial Virus
  24. Influenza “Trains” the Host for Enhanced Susceptibility to Secondary Bacterial Infection
  25. Novel role of gastrin releasing peptide-mediated signaling in the host response to influenza infection
  26. Cotton rat lung transcriptome reveals host immune response to Respiratory Syncytial Virus infection
  27. Improving ability of RSV microneutralization assay to detect G-specific and cross-reactive neutralizing antibodies through immortalized cell line selection
  28. A multifaceted approach to RSV vaccination
  29. Efficacy of a respiratory syncytial virus vaccine candidate in a maternal immunization model
  30. Serum High-Mobility-Group Box 1 as a Biomarker and a Therapeutic Target during Respiratory Virus Infections
  31. Cotton rat model for testing vaccines and antivirals against respiratory syncytial virus
  32. Enhancing the Thermostability and Immunogenicity of a Respiratory Syncytial Virus (RSV) Live-Attenuated Vaccine by Incorporating Unique RSV Line19F Protein Residues
  33. Immunization with Live Human Rhinovirus (HRV) 16 Induces Protection in Cotton Rats against HRV14 Infection
  34. Preclinical assessment of safety of maternal vaccination against respiratory syncytial virus (RSV) in cotton rats
  35. TLR4 antagonist FP7 inhibits LPS-induced cytokine production and glycolytic reprogramming in dendritic cells, and protects mice from lethal influenza infection
  36. A live RSV vaccine with engineered thermostability is immunogenic in cotton rats despite high attenuation
  37. Enterovirus D-68 Infection, Prophylaxis, and Vaccination in a Novel Permissive Animal Model, the Cotton Rat (Sigmodon hispidus)
  38. Evaluation of the potential effects of AS03-adjuvanted A(H1N1)pdm09 vaccine administration on the central nervous system of non-primed and A(H1N1)pdm09-primed cotton rats
  39. Epigenetic Mechanisms Governing Innate Inflammatory Responses
  40. A Recombinant Respiratory Syncytial Virus Vaccine Candidate Attenuated by a Low-Fusion F Protein Is Immunogenic and Protective against Challenge in Cotton Rats
  41. Enhanced allergic responsiveness after early childhood infection with respiratory viruses: Are long-lived alternatively activated macrophages the missing link?
  42. Novel strategies for targeting innate immune responses to influenza
  43. Cotton rat immune responses to virus-like particles containing the pre-fusion form of respiratory syncytial virus fusion protein
  44. Maternal transfer of RSV immunity in cotton rats vaccinated during pregnancy
  45. Treatment with novel RSV Ig RI-002 controls viral replication and reduces pulmonary damage in immunocompromised Sigmodon hispidus
  46. Efficacy of the Herpes Simplex Virus 2 (HSV-2) Glycoprotein D/AS04 Vaccine against Genital HSV-2 and HSV-1 Infection and Disease in the Cotton Rat Sigmodon hispidus Model
  47. Novel drugs targeting Toll-like receptors for antiviral therapy
  48. Agents that increase AAM differentiation blunt RSV-mediated lung pathology
  49. A recombinant anchorless respiratory syncytial virus (RSV) fusion (F) protein/monophosphoryl lipid A (MPL) vaccine protects against RSV-induced replication and lung pathology
  50. Modeling Human Respiratory Viral Infections in the Cotton Rat (Sigmodon hispidus)
  51. Prophylactic antibody treatment and intramuscular immunization reduce infectious human rhinovirus 16 load in the lower respiratory tract of challenged cotton rats
  52. Role of the lipoxygenase pathway in RSV-induced alternatively activated macrophages leading to resolution of lung pathology
  53. The TLR4 antagonist Eritoran protects mice from lethal influenza infection
  54. The Cotton Rat Sigmodon Hispidus Model of Respiratory Syncytial Virus Infection
  55. Chronic Helminth Infection Does Not Exacerbate Mycobacterium tuberculosis Infection
  56. Receptor Characterization and Susceptibility of Cotton Rats to Avian and 2009 Pandemic Influenza Virus Strains
  57. Respiratory Syncytial Virus Fusion Protein-Induced Toll-Like Receptor 4 (TLR4) Signaling Is Inhibited by the TLR4 Antagonists Rhodobacter sphaeroides Lipopolysaccharide and Eritoran (E5564) and Requires Direct Interaction with MD-2
  58. The anti-tumor agent, 5,6-dimethylxanthenone-4-acetic acid (DMXAA), induces IFN-β-mediated antiviral activity in vitro and in vivo
  59. New insights for development of a safe and protective RSV vaccine
  60. Activation of Interferon Response Through Toll-Like Receptor 3 Impacts Viral Pathogenesis and Pulmonary Toll-Like Receptor Expression During Respiratory Syncytial Virus and Influenza Infections in the Cotton RatSigmodon hispidusModel
  61. Control of RSV-induced lung injury by alternatively activated macrophages is IL-4Rα-, TLR4- and IFN-β-dependent
  62. Methods for Monitoring Dynamics of Pulmonary RSV Replication by Viral Culture and by Real‐Time Reverse Transcription–PCR In Vivo: Detection of Abortive Viral Replication
  63. Inactivation of respiratory syncytial virus by zinc finger reactive compounds
  64. The cotton rat model of respiratory viral infections
  65. Characterization of late tuberculosis infection in Sigmodon hispidus
  66. Expression of Human CD4 and chemokine receptors in cotton rat cells confers permissiveness for productive HIV infection
  67. Induction of type I interferons and interferon-inducible Mx genes during respiratory syncytial virus infection and reinfection in cotton rats
  68. Co-infection of the cotton rat (Sigmodon hispidus) with Staphylococcus aureus and influenza A virus results in synergistic disease
  69. The Antiviral Potential of Interferon-Induced Cotton Rat Mx Proteins Against Orthomyxovirus (Influenza), Rhabdovirus, and Bunyavirus
  70. Association of TLR4 Polymorphisms with Symptomatic Respiratory Syncytial Virus Infection in High-Risk Infants and Young Children
  71. Respiratory Syncytial Virus Infects and Abortively Replicates in the Lungs in Spite of Preexisting Immunity
  72. Human metapneumovirus: Enhanced pulmonary disease in cotton rats immunized with formalin-inactivated virus vaccine and challenged
  73. The American cotton rat: A novel model for pulmonary tuberculosis
  74. Age‐Related Differences in Pulmonary Cytokine Response to Respiratory Syncytial Virus Infection: Modulation by Anti‐inflammatory and Antiviral Treatment
  75. Interferon-Inducible Mx Gene Expression in Cotton Rats: Cloning, Characterization, and Expression During Influenza Viral Infection
  76. Analysis of TLR4 Polymorphic Variants: New Insights into TLR4/MD-2/CD14 Stoichiometry, Structure, and Signaling
  77. The TLR4 agonist, monophosphoryl lipid A, attenuates the cytokine storm associated with respiratory syncytial virus vaccine-enhanced disease
  78. Prospects of antiviral and anti-inflammatory therapy for respiratory syncytial virus infection
  79. The cotton rat provides a useful small-animal model for the study of influenza virus pathogenesis
  80. Pathogenesis of Human Metapneumovirus Lung Infection in BALB/c Mice and Cotton Rats
  81. Respiratory Syncytial Virus (RSV) Infection Induces Cyclooxygenase 2: A Potential Target for RSV Therapy
  82. The Cotton Rat: An Underutilized Animal Model for Human Infectious Diseases Can Now Be Exploited Using Specific Reagents to Cytokines, Chemokines, and Interferons
  83. Distinct Mutations inIRAK-4Confer Hyporesponsiveness to Lipopolysaccharide and Interleukin-1 in a Patient with Recurrent Bacterial Infections
  84. A Cotton Rat Model of Human Parainfluenza 3 Laryngotracheitis: Virus Growth, Pathology, and Therapy
  85. The role of the interferon regulatory factors, IRF-1 and IRF-2, in LPS-induced cyclooxygenase-2 (COX-2) expression in vivo and in vitro
  86. Cytokine and Chemokine Gene Expression after Primary and Secondary Respiratory Syncytial Virus Infection in Cotton Rats
  87. Emerging genetic diversity of HIV-1 in South America
  88. Interferon Regulatory Factor (Irf)-1 and Irf-2 Regulate Interferon γ–Dependent Cyclooxygenase 2 Expression
  89. Limited Role of Ceramide in Lipopolysaccharide-mediated Mitogen-activated Protein Kinase Activation, Transcription Factor Induction, and Cytokine Release
  90. The histone acetylase PCAF is a nuclear receptor coactivator
  91. Retinoid Receptor-Induced Alteration of the Chromatin Assembled on a Ligand-Responsive Promoter inXenopusOocytes
  92. Interaction between the Retinoid X Receptor and Transcription Factor IIB Is Ligand-dependentin Vivo
  93. Mutations in the 1,25-Dihydroxyvitamin D3Receptor Identifying C-terminal Amino Acids Required for Transcriptional Activation That Are Functionally Dissociated from Hormone Binding, Heterodimeric DNA Binding, and Interaction with Basal Transcription Fac...
  94. Myeloid differentiation is impaired in transgenic mice with targeted expression of a dominant negative form of retinoid X receptor β
  95. Interferon regulatory factors and TFIIB cooperatively regulate interferon-responsive promoter activity in vivo and in vitro.
  96. Inhibition of ligand induced promoter occupancyin vivoby a dominant negative RXR
  97. Transcription factor TFIIB and the vitamin D receptor cooperatively activate ligand-dependent transcription.
  98. Retinoic acid induction of major histocompatibility complex class I genes in NTera-2 embryonal carcinoma cells involves induction of NF-kappa B (p50-p65) and retinoic acid receptor beta-retinoid X receptor beta heterodimers.
  99. Repetitive DNA sequences of Toxoplasma gondii for development of diagnostic probes
  100. Toxoplasma gondii: a rapid method for the isolation of pure tachyzoites: preliminary characterization of its genome